Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $704,738 | $1,778,176 | $1,912,595 | $1,891,777 |
| - Cash | $88,559 | $92,154 | $656,203 | $620,129 |
| + Debt | $599,481 | $715,538 | $415,915 | $475,802 |
| Enterprise Value | $1,215,660 | $2,401,560 | $1,672,307 | $1,747,450 |
| Revenue | $351,410 | $442,735 | $410,596 | $413,753 |
| % Growth | -20.6% | 7.8% | -0.8% | – |
| Gross Profit | $343,858 | $436,587 | $409,178 | $343,348 |
| % Margin | 97.9% | 98.6% | 99.7% | 83% |
| EBITDA | $97,728 | $197,411 | $261,438 | $233,738 |
| % Margin | 27.8% | 44.6% | 63.7% | 56.5% |
| Net Income | $880 | -$1,002,239 | $175,065 | $528,448 |
| % Margin | 0.3% | -226.4% | 42.6% | 127.7% |
| EPS Diluted | 0.006 | -6.45 | 0.96 | 3.21 |
| % Growth | 100.1% | -771.9% | -70.1% | – |
| Operating Cash Flow | $103,549 | $183,427 | $273,763 | $261,895 |
| Capital Expenditures | -$142 | -$273 | -$136 | -$265 |
| Free Cash Flow | $103,407 | $183,154 | $273,627 | $261,630 |